Skip to main navigation Skip to search Skip to main content

Pharmacological enhancement of fear extinction

  • Brett J. Davis
  • , Benjamin M. Rosenberg
  • , Matthew G. Kearney
  • , Michael Treanor
  • , Michelle G. Craske
  • , Tom Barry
  • University of California
  • Harvard University
  • University of California, Los Angeles

Research output: Contribution to journalReview articlepeer-review

7   Link opens in a new tab Citations (SciVal)

Abstract

Pharmacological agents theorized to modulate fear extinction could enhance
treatments for anxiety and trauma-related disorders, but fear conditioning and
treatment studies testing these agents often yield null or conflicting results. We review principles of extinction learning relevant to the design of studies that test
pharmacological enhancements of extinction. We then critically review the methodologies of existing studies for three pharmacological agents [d-cycloserine
(DCS), glucocorticoids (GCs), and L-DOPA] with respect to key learning principles.
While each agent has promising support in rodent models, many human studies
are not designed to adequately detect an agent’s effects on extinction learning.
We provide specific recommendations, informed by these learning principles,
for future study designs that may clarify whether, how, and under what conditions
agents impact extinction.
Original languageEnglish
Pages (from-to)162-174
JournalTrends in Cognitive Sciences
Volume30
Issue number2
Early online date9 Jul 2025
DOIs
Publication statusPublished - 28 Feb 2026

Funding

The present review was not supported by any funding source.

Keywords

  • D-cycloserine
  • L-DOPA
  • exposure therapy
  • fear extinction
  • glucocorticoids

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Experimental and Cognitive Psychology
  • Cognitive Neuroscience

Fingerprint

Dive into the research topics of 'Pharmacological enhancement of fear extinction'. Together they form a unique fingerprint.

Cite this